Preclinical studies and clinical trials have shown that targeting CD24 can significantly reduce lung metastases in bladder cancer and target liver cancer stem cells, highlighting its role in the development of metastases and its necessity for the proliferation of certain cancer cells (286). Here, CD24 is linked to liver cancer.